FDA Approves Margenza

FDA Approves Margenza (margetuximab-cmkb) for Patients with Pretreated Metastatic HER2-Positive Breast Cancer ROCKVILLE, MD, Dec. 16, 2020 (GLOBE NEWSWIRE) —  MacroGenics, Inc. (Nasdaq: MGNX), a […]

Read more

FDA Approves Detectnet

FDA Approves Detectnet (copper Cu 64 dotatate injection) Positron Emission Tomography (PET) Agent Houston, TX and St. Louis, MO, Sept. 08, 2020 (GLOBE NEWSWIRE) — […]

Read more
1 2 3 5